Concepedia

Giorgi Dzagnidze

GD

Statistics

Publications

7

Citations

233

H-Index

7

Active since

2006

Affiliations

St. Luke's Medical Center(Current)

Celltrion (South Korea)

City Clinical Oncology Center

Kyiv City Clinical Oncology Center

Centrum Onkologii

Giorgi Dzagnidze is an author at St. Luke's Medical Center specializing in breast cancer, medicine, and oncology.

Top concepts

Publications per year

2006–2022

7

Publications

7

CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial

Justin Stebbing, Y. Baranau, Valeriy Baryash et al. · The Lancet Oncology · 2017 · 119 citations · Full text

, , +9

Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial

Francisco J. Esteva, Y. Baranau, V. Baryash et al. · Cancer Chemotherapy and Pharmacology · 2019 · 31 citations · Full text

Effects of fulvestrant 250mg in premenopausal women with oestrogen receptor-positive primary breast cancer

J.F.R. Robertson, Semiglazov Vf, Gia Nemsadze et al. · European Journal of Cancer · 2006 · 26 citations

, , +9

Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial

Justin Stebbing, Y. Baranau, V. Baryash et al. · Breast Cancer Research and Treatment · 2021 · 21 citations · Full text

Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer Treated in the Neoadjuvant Setting

Xavier Pivot, V.A. Shamrai, Giorgi Dzagnidze et al. · JAMA Oncology · 2022 · 13 citations · Full text

1–5 of 7